INVITED PRESENTATIONS JULY 1, 2009 – JUNE 30, 2010
Michelle Alfa
Keynote Address: “Biosafety Issues Related to Reprocessing of Medical Devices in an Ever-Changing Healthcare
Environment.” Canadian Biosafety Symposium, Winnipeg, MB, June 8, 2010.
Keynote Speaker: “Reprocessing of Implantables.” OHA Conference in Toronto, ON. March 21, 2010.
“Methicillin Resistant
Health, Steinbach. May 18, 2010.
A Pathogen of Increased Importance in Manitoba.” South Eastman
“How important is the cleaning process for laparoscopic equipment.” Presented at Brazilian SOBECC 9 th Congress of Operating Room Nursing, Anesthesia Recovery and Material Storage and Sterilization. Sau Paulo, Brazil. July
20, 2009.
“Validation of the cleaning and sterilization process for medical instruments.” Presented at Brazilian SOBECC 9 th
Congress of Operating Room Nursing, Anesthesia Recovery and Material Storage and Sterilization. Sau Paulo,
Brazil. July 20, 2009.
Anton Andonov
Current relevance of arbovirus infections in transfusion medicine. A.Andonov; XXXIst International congress of the International Society for Blood transfusion, Berlin, June 26-July 1st, 2010.
Dengue virus as a potential threat to the safety of the blood supply in Brazil. A. Andonov, E. Grudeski, E. Levi,
M. Drebot, S. Wendel and K. Ferguson. Emerging Arboviruses: evaluating the threat to transfusion and transplantation safety. US Food and Drug Administration; December 14-15, 2009, Bethesda.
Fred Aoki
September 2-3, 2009. Antiviral Therapy. Severe H1N1 Disease: Preventing Cases, Reducing Mortality Meeting,
Winnipeg, Manitoba.
October 21, 2009. Pandemic Swine-Origin Influenza A Virus (S-OIV) [H1N1]. Respiratory Health Professionals
H1N1 Meeting, Winnipeg, Manitoba.
November 23, 2009. Influenza – H1N1. Philippines Nurses’ Association of Manitoba, Winnipeg.
March 13, 2010. Antiviral Drugs for Cold and Flu. Lecture in conjunction with Honour’s Thesis Student
Presentations, University of Winnipeg, Manitoba; Dr. M. Wiegand (Chair).
Harvey Artsob
National and international activities undertaken at the National Microbiology Laboratory, Public Health Agency of
Canada. Creative Retirement Manitoba. October 8, Winnipeg, Manitoba, 2009.
Overview of activities of the PAHO/WHO Collaborating Centre for Emerging and Zoonotic Diseases: Detection,
Diagnostics, Reference and Research. Canadian PAHO/WHO Collaborating Centre Workshop. October 23-24,
Ottawa, Ontario, 2009.
Addressing infectious disease threats to Canadians; a zoonotic diseases perspective. Invited presentation at
Rocky Mountain Laboratory, National Institute of Allergy and Infectious Diseases (NIAID). November 19,
Hamilton, Montana, 2009.

Zoonotic Diseases reflections. Invited presentation at the Canadian Science Centre for Human and Animal Health to mark my retirement. January 13, Winnipeg, Manitoba, 2010.
Laboratory studies to determine dengue virus infections. Generating knowledge on dengue prevention through eco-bio-social research Workshop. May 23-25, Dhaka, Bangladesh, 2010.
Into the future: zoonotic diseases and the health of Canadians. Canadian Public Health Association Centennial
Conference. June 15, Toronto, Ontario, 2010.
Blake Ball
Coordinating Medical Research and Education in Times of Crisis Invited Talk: East-West Alliance 2010 Conference,
Winnipeg, Manitoba, June 3, 2010.
HIV-1 resistant sex workers overexpress novel antiproteases and antiviral factors in their cervical mucosa. A protective milieu against HIV Infection? Oral presentation 19 th Annual Canadian Conference on HIV/AIDS
Research, Saskatoon, Saskatchewan, May 15, 2010.
Immune Quiescence: A model for protection from HIV infection at the female genital tract. Invited visiting speaker Rush University Medical Center, Chicago, Illinois April 26, 2010.
The role of Immune Quescence in protecting against HIV? Invited Talk: Collaboration for AIDS Vaccine Discovery
Annual Meeting, Miami, Florida Dec 1 – 4, 2009.
The role of CD8 T cell responses in protecting against HIV? Lessons for vaccine development? Invited talk:
International Course on Clinical and Research Applications of Flow Cytometry , Yaounde, Cameroon Oct 8-10,
2009.
Introduction to QASI: An International External Quality Assessment (EQA) Program. Invited talk: International
Course on Clinical and Research Applications of Flow Cytometry , Yaounde, Cameroon Oct 8-10, 2009.
Identification of Differentially expresses proteins in the Cervical Mucosa. Invited talk: NIH Workshop-Evaluation of Cellular Mucosal Immunity June 15-16, 2010 Potomac MD.
Marissa Becker
HIV in Manitoba: an update from the Manitoba HIV Program. Presentation at the “Partners in Caring” Conference,
Winnipeg, Manitoba. March 17, 2010.
HIV Vaccines: the hope and the frustration. Department of Internal Medicine Grand Rounds, University of
Manitoba, Winnipeg, Canada. February 9, 2010 (together with Dr. Keith Fowke).
Kathryn Bernard
Bacterial Culture and Identification: an Introduction. Laboratory Course for Field Epidemiologists. September 2009 at the CSCHAH Winnipeg MB.
Medically Relevant Gram Positive Rods or Coccobacilli. Jan. 6. 2010 Clinical Microbiology, MMIC 7040. Department of Medical Microbiology, Bannatyne Campus, University of Manitoba, Winnipeg MB.
: an overview. March 10, 2010. Clinical Microbiology, MMIC 7040. Dep’t Medical Microbiology,
Bannatyne Campus, University of Manitoba, Winnipeg MB.
Registered Microbiologist (RM) as defined under the new rules of the CCM with respect to the CSCHAH. Canadian
College of Microbiologists (CCM) meeting of the executive May 5, 2010.

Updated look at
species and other medically-relevant, fastidious or good-growing Gram positive
Rods, an all day workshop for the South Western Association of Clinical Microbiology (‘SWACM’) held May 21,
2010 in Arlington TX. Part One: Overview and
Gram Positive Rods. Arlington TX.
species; Part Two: Coryneforms and other
Timothy Booth
ViroNet Update. CPHLN Spring Semi-Annual meeting, Winnipeg, Manitoba, 28
Eric Bow
August 28, 2009 th April 2010.
Saskatchewan Cancer Agency, Pasqua Hospital, Regina, SK.
Topic of Presentation: Fungal Infections in the Immunocompromised Patient
October 18-27, 2009 Speaking Tour in Australia in conjunction with the Haematology
Society of Australia and New Zealand (HSANZ), Adelaide, Australia.
Additional presentations in Perth, Brisbane, Melbourne, Sydney.
Presentation titles:
1.
Early therapy of invasive fungal infections in high-risk patients: Prevention, Preemption, & Empiricism … Competing Strategies or Additive Value?
Combination anti-fungal therapy of invasive fungal infection in high-risk patients.
Invasive fungal infection in high-risk patients: What should physicians know to
November 9, 2009
2.
3.
optimize outcome of anti-fungal chemotherapy?
4.
Risk stratification in preventing Invasive Fungal Infection in high-risk patients: How, then shall we avoid catching our death of mould?
5.
2009: A Pandemic Odyssey: Considerations for A/H1N1 in Cancer Patient
Populations.
University of Calgary, Department of Medicine
Visiting Academic Speaker
February 9, 2010
Presentation: “Invasive Fungal Infections in High Risk Patients. What Should
Physicians Know to Optimize Outcome of Anti-fungal Chemotherapy?”
Followed by Case Presentations with ID Fellows, University of Calgary
Haematology/Oncology Regional Grand Rounds
Section of Haematology/Oncology, Department of Internal Medicine, UofM
Presentation: “2010: Pandemic Odyssey Continues...”
February 18-21, 2010 2010 Winter Congress for Korean Society for Bone Marrow Transplantation, Muju, Korea
Presentation: “Invasive Fungal Infection in Allogeneic Haematopoietic Stem Cell
Transplant Recipients: What Physicians Should Consider to Optimize Management”
March 3-5, 2010 Focus on Fungal Infections (FOFI) meeting, New Orleans, LA
1.
Presentation: “The alimentary tract and candidiasis in neutropenic patients”
2.
Case Presentation: “Septic shock caused by Candida albicans in a patient with acute leukemia”
3.
Presentation: “How I treat aspergillosis in patients with acute leukemia: Any role for combination antifungal therapy?”
April 10-11, 2010 Taiwan Society of Blood and Marrow Transplantation, Taipei, Taiwan.
Presentation: Invasive Fungal Infection in high-risk patients with Haematological
Malignancies: Considerations for the systematic approach. Additional Clinical
Teaching/Grand Rounds sessions in teaching hospitals in Taipei and Taichung on “Clinical
Practice for managing potential patients with invasive fungal infections”.

David Butler-Jones
(* Does not include speeches/presentations for H1N1, before Committee or for debates *)
July 11, 2009 - 14 th International Congress on Circumpolar Health – Keynote, Yellowknife
September 2-5, 2009 - International Conference on Severe H1N1 Disease: Preventing Cases, Reducing Mortality –
Welcoming and Closing Remarks, Winnipeg
September 11, 2009 - Federation of Canadian Municipalities Board Meeting, Collingwood
September 14, 2009 - Policy Forum on Social Determinants of Health: Federal Leadership and the Canadian
Context, Ottawa
September 21, 2009 - Canadian Academy of Health Sciences Symposium on Canada’s Strategic Role in Global
Health, Panel Discussion, Ottawa
September 22, 2009 - Heads of Federal Agencies Luncheon: "Stability in Unstable Times:Ensuring Continuity during an Influenza Pandemic", Ottawa
September 24, 2009 – Conference Board of Canada - Where Are We Today? A Pandemic Reality Check, Toronto
October 15, Health Over the Life Course Conference, London, ON
October 20, Canadian Association for Suicide Prevention, Saskatoon, SK
October 23 – Maple Leaf Food Safety Symposium, Toronto
October 27, 2009 – Deputy Ministers’ Committee on Agriculture, Ottawa
October 28, 2009 – Canadian Airports Council, Toronto
October 29, 2009 – University of Ottawa Nursing Program, Ottawa
November 12, 2009 – Canadian Club of Ottawa, Ottawa
November 17, 2009 – Canadian Teachers’ Federation Board Meeting, Ottawa
November 24, 2009 – National Aboriginal Health Organization Conference, Ottawa
November 25, 2009 – Refugee Health Conference, Toronto
December 7, 2009 – Diabetes Day on the Hill, Ottawa
December 10, 2009 – Injury Prevention Workshop, Ottawa
February 10, 2010 – Eggs & Icons Breakfast, Ottawa
February 14, 2010 – St. Andrew’s College, Winnipeg
February 17, 2010 – Manitoba Hydro H1N1 Task Force, Winnipeg
March 25, 2010 – Northern Ontario School of Medicine, Sudbury
March 30, 2010 – Ottawa University School of Health Sciences, Ottawa
April 15, 2010 – Public Service Executive Conference, Montebello, QC

April 21, 2010 – International Health Regulations Roundtable, Toronto
April 23, 2010 – Canadian Association of Radiologists Annual Scientific Meeting, Montreal
April 26, 2010 – Healthcare Leaders Innovation and Policy Forum, Toronto
May 5, 2010 – International Physical Activity Conference, Toronto
May 10, 2010 – Canadian Institutes of Health Research Public Health Policy Dinner, Ottawa
May 17, 2010 – World Health Association, Geneva
June 1, 2010 – APEX Conference, Ottawa
June 14, 2010 – Canadian Public Health Association (keynote), Toronto
June 14, 2010 – National Violence Prevention Conference, Toronto
June 17, 2010 – National Community Health Nurses Conference, Toronto
Kevin Coombs
“Omics” of influenza virus-host functions. Pandemic Preparedness Strategic Research Initiative, Toronto, July 8,
2009.
Genomics to identify host pathogenesis genes. Joint Canada U.K. International Antiviral Conference, London,
October 15, 2009.
Maryanne Crockett
M Crockett, S Fanella, P Lagace-Wiens. Gorgas on the Prairies: Clinical Cases in Parasitology and Tropical
Medicine; Medical Microbiology Seminar Series – November 19, 2009.
M Crockett, J Embree, S Fanella, P VanCaeseele, J Kettner. Pandemic (H1N1) 2009 Influenza in Children and
Youth: Clinical Experience and Lessons Learned; Pediatric Grand Rounds, University of Manitoba – October 8,
2009.
M Crockett. Vaccine Development and Evaluation and Adverse Events Following Immunization; Immunization
Competencies Course – December 4, 2009.
Michael Drebot
Drebot M. Severe H1N1 Research: Critical Questions, PHAC Meeting of “Severe H1N1 Disease: Preventing Cases,
Reducing Mortality”. Winnipeg, MB, September 2-3, 2009.
Andonov A, Grudeski, E, Levi E, Drebot M, Wendel N, Ferguson K. DENGUE VIRUS AS A POTENTIAL THREAT TO th Regional THE SAFETY OF THE BLOOD SUPPLY IN BRAZIL. International Society of Blood Transfusion, 20
Congress, Asia. Nagoya Japan, November 14-18 th , 2009.
Drebot M. Distribution and genetic relatedness of mosquito-specific flaviviruses: From Canada to California “in
Symposium 7- Newly Described Mosquito-Specific Flaviviruses: Geographic Distribution, Genetic Relatedness and
Potential Role for Augmentation of Heterologus Infections”. 58 th Annual Meeting of the American Society of
Tropical Medicine and Hygiene. Washington, DC, USA. November 18-22, 2009.

Drebot MA. Diagnostic considerations when testing for antibodies to California serogroup viruses. Subcommittee on Interrelationships Among Catalogued Arboviruses. 58 th Annual Meeting of the American Society of Tropical
Medicine and Hygiene. Washington, DC, USA. November 18-22, 2009.
Drebot M, Grudeski, Levi E, Wendel N, Ferguson K, Andonov A. An assessment of dengue virus as a threat to the safety of the blood supply in Brazil. 4 th Asian Dengue Research Network Meeting. Singapore, December 8-11,
2009.
Drebot M. Diagnostic considerations for emerging zoonotic disease. Zoonotic Diseases Symposium, Annual
Review Meeting of the University of Nairobi STD/AIDS Collaborative Group. Nairobi, Kenya. January 26-29,
2010.
Drebot M. California serogroup viruses in Canada: an update on research and surveillance. National Non-Enteric
Zoonoses Workshop, Ottawa Ontario February 25, 2010.
Drebot MA, Mosquito-borne viruses: an update on West Nile virus and other arboviruses in Canada. University of
Manitoba, Medical Microbiology Seminar, February 22, 2010.
Drebot MA, Arbovirus Encephalides. University of Manitoba, Medicine Grand Rounds, April 23, 2010.
Drebot MA, Zoonotic Diseases: A Canadian Perspective. The Microbrial Hour, Division of Infectious Diseases,
Capital Health & QE2, Health Sciences Centre, Halifax, Nova Scotia, June 9, 2010.
John Embil
Embil JM. Never a Dull Moment! Case History in Infectious Diseases. University of Manitoba Continuing Medical
Education Program for Primary Care Physicians – Flin Flon, Manitoba, October 7, 2009.
Embil JM. Staying in Control – Infection Prevention and Control. Internal Medicine Grand Rounds, University of
Manitoba, Winnipeg, Manitoba, October 20, 2009.
Embil JM. Germs are Everywhere. Education Event of the Manitoba Branch – The Kidney Foundation of Canada.
Winnipeg, Manitoba, November 22, 2009.
Embil JM. Woundcare. Community-Based Continuing Medical Education – Family Physician Program, University of Manitoba for Burntwood Region (Thompson), Churchill Region (Churchill), Nor-Man Region (Flin Flon), and
Nor-Man Region (The Pas). March 11, 2010.
Embil JM. Treatment of Urinary Tract Infections. Continuing Medical Education Program for Primary Care
Practitioners. Winnipeg, Manitoba, March 13, 2010.
Embil JM. Infectious Diseases Society of America Guidelines: Opening the Kimono on Simple Evidence-Based
Tips. DF Con 2010, Diabetic Foot Global Conference, Los Angeles, California March 19, 2010.
Embil JM. Infection in the Diabetic Foot: Diagnosis and Management. Winnipeg Regional Health Authority
Advanced Woundcare Education Day: Wound Infections. Winnipeg, Manitoba, March 26, 2010.
Embil JM. Round Table Discussion on Wound and Diabetic Foot Care. Manitoba Club, Winnipeg, Manitoba, April
9, 2010.
Embil JM. Update in the Diabetic Foot. Advances in Vascular Nursing Conference. St. Boniface General Hospital,
April 21, 2010.
Embil JM. Opening Address. 22 nd Annual Health Sciences Centre Volunteer Recognition Dinner. Winnipeg,
Manitoba, April 29, 2010.

Embil JM. Hot Topics in Infectious Diseases. Continuing Medical Education Program for Family Physicians:
Therapeutic Update. University of Manitoba, Winnipeg, Manitoba, May 7, 2010.
Embil JM. Amputee Symposium: Diabetic Foot Ulcers – Evaluation and Treatment. Canadian Association of
Physical Medicine Rehabilitation 58 th Annual Scientific Meeting, May 29, 2010, Winnipeg, Manitoba.
Embil JM, Blake M. Creative Solutions to Real Life Infection Prevention and Control Situations. Advanced
Practitioner Day, 2010 Education Conference. Community and Hospital Infection Control Association – Canada.
Vancouver, British Columbia, May 30, 2010.
Embil JM, Blake M. Case Scenarios. Novice Practitioner Day, 2010 Education Conference. Community and
Hospital Infection Control Association – Canada. Vancouver, British Columbia, May 30, 2010.
Joanne Embree
Pandemic H1N1 2009 Influenza (Swine flu): The Manitoba Experience. 2 nd International Symposium on Recent
Advances in Basic, Clinical and Social Medicine. Shantou, China. Nov 24-26, 2009.
Adverse effects of vaccines. 3
10-12, 2010.
SARS and Influenza H1N1. 3
10-12, 2010. rd Reunion of the Americas Meeting. World Trade Center, Mexico City, Mexico, Feb rd Reunion of the Americas Meeting. World Trade Center, Mexico City, Mexico, Feb
Impact of H1N1 on Global Health. East-West Alliance Meeting, Winnipeg, June 17-18, 2010.
H1N1: Looking back – looking forward, 87th Annual Conference Canadian Paediatric Society, Vancouver, BC, June
22-26, 2010.
Heinrich Feldmann
Molecular vaccines for filoviruses. Innovations in Molecular Approaches to Vaccine Delivery. Thirteenth Annual
Conference on Vaccine Research. National Foundation for Infectious Diseasesa. Bethesda, Maryland, United
States (2010).
Pre- and postexposure vaccination for viral hemorrhagic fevers. Global COE Seminar, Hokkaido University,
Sapporo, Japan (2010)
Postexposure vaccination for filoviruses. 5th International Symposium on Filoviruses, Tokyo, Japan (2010)
Laboratory response to emerging exotic viral diseases. University of Montana, Missoula, Montana, United Sates
(2010)
Filovirus glycoproteins - biology, pathogenesis and immunogenicity. Department of Microbiology and
Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, United States (2010)
Marburg and Ebola viruses. University of Washington, Seattle, Washington, United States (2010)
Marburg and Ebola Viruses: pre- and post-exposure vaccination. Sealy Center for Vaccine Development
Symposium, Galveston, texas, USA (2009)
Pre- and post-exposure vaccination for viral hemorrhagic fevers. Infection of the Endothelium, 1 st International
Symposium, Dresden, Germany (2009)
Response to viral hemorrhagic fevers: on-site diagnostic and vaccines. Bernhard-Nocht-Institut, Hamburg,
Germany (2009)

Filoviruses: pathogenesis and host response. Microbiology & Molecular Genetics Program, MMG Student
Symposium, Emory University, Atlanta, Georgia, USA (2009)
Function of Ebola virus glycoproteins in pathogenesis and immune response. Technische Universitaet, Dresden,
Germany (2009)
Function of Ebola Virus Glycoproteins in Pathogenesis and Immune Response. University of Montana, Division of
Biological Science. Montana Biotechnology Center. Missoula, Montana, USA (2009)
Ebola and Marburg Viruses: Epidemiology, Ecology and Host Adaptation. Zoonoses: Diseases from nature. Yale
School of Public Health. New Haven, CT, USA (2009)
Keith Fowke
“Conducting research and training in the heart of the HIV pandemic” East/West Alliance 2010 Conference.
Winnipeg, Manitoba, June 3-4, 2010.
“Resisting HIV infection through Immune Quiescence” Prairie Infectious Immunology Network. Saskatoon,
Saskatchewan, June 16-18 2010.
“Career Development and Future Career Prospects”. Second Immunology Mentorship Program. Winnipeg,
Manitoba. June 23 rd
Matthew Gilmour
2010.
2009. NARMS – National Antimicrobial Resistance Monitoring System (CDC, FDA, USDA); Annual Meeting and
Interagency Laboratory Working Groups. Invited lecture in “High Throughput Genome Sequencing for Outbreak
Response”, August 5-7, 2009, Rockville, MD, USA
2009. Federal Food Safety and Nutrition Research Meeting 2009. High-Throughput Genome Sequencing of Two
Clinical Isolates During a Large Foodborne Outbreak. November 4-5, 2009. Ottawa, ON.
2010. Annual Strategic Planning Meetings of the Bureau of Microbial Hazards, Health Canada. Overview of the
Enteric Diseases Program. January 29 th , 2010. Ottawa, ON.
Morag Graham
National Bioscience Educators Conference Delegation, St. Boniface Research Centre, Winnipeg, MB, Feb 17,
2010: “Genomics in public health”.
Daryl Hoban
Aug 26-27/09 – Invited speaker, Abbott Symposium, Singapore
Aug 29-30/09 – Invited speaker, Abbott Symposium, Vietnam
June 4/10 – Invited speaker, Merck Asia Pacific SMART Investigators Meeting, Singapore
June 5-6/10 – Invited speaker, Merck Asia Pacific ID Speaker’s Forum, Philippines
Alan Jackson
Insights into the pathogenesis of rabies. Platform presentation at the Manitoba Neuroscience Network Conference in Winnipeg, Manitoba on June 14, 2010.
Tomy Joseph
Swine Influenza: Emergence of new viruses. Manitoba Swine Seminar. Winnipeg, Manitoba, Canada. February 3-
4, 2010

Joshua Kimani
Identifying research priorities for HIV prevention in MSM in Africa” 26 February 2010, 8.30 – 4 pm, KEMRI –
Wellcome Trust, Kilifi
Research Workshop for Innova P2 – Melbourne March 24-26, 2010.
Guest speaker on; "Aids, Malaria, Tuberculosis – How Pharmaceutical Innovation fails the Poor." http://www.philosophy.unimelb.edu.au/assets/pdf/cappe-march-2010.pdf
David Knox
Prion biology: The Quest for the Test. University of Arizona, Tucson, Arizona. June 2010.
Identification of urine based biomarkers using 2D-DIGE. PrP 2010 Satellite Meeting, Ottawa, Ontario, March 2010
Comparative Proteomics: Searching for Surrogate markers. PrP 2010, Ottawa, Ontario, March 2010.
Prion Pathogenesis. Pharmacology Department, University of Manitoba, Winnipeg, Manitoba, January 2010.
Gary Kobinger
Tokyo, April 2010
Quebec, June 2010
Public Security S&T Summer Symposium 2010, Ottawa, June 2010
Filovirus Medical Countermeasures (MCM) Workshop, Gaithersburg Maryland, June 2010
Anand Kumar
H1N1 Infection in ICU. Canadian Pandemic Preparedness Meeting: H1N1 Outbreak Research Response (Toronto,
ON) July 8, 2009
Severe H1N1 In Manitoba ICUs. Canadian Pandemic Preparedness Meeting: H1N1 Outbreak Research Response
(Toronto, ON) July 8, 2009
Antimicrobial Use in the ICU. Multiprofessional Critical Care Review Course 2009 (San Francisco, CA) July 15,
2009
Multi-resistant Infections. Multiprofessional Critical Care Review Course 2009 (San Francisco, CA) July 15, 2009
Infections in AIDS, Transplant Patients and other Immunocompromised Hosts. Multiprofessional Critical Care
Review Course 2009 (San Francisco, CA) July 16, 2009
Lessons from the ICU: The Winnipeg H1N1 Outbreak. Ottawa CME Telecast/Manitoba TeleHealth Service
(Winnipeg, MB) July 29, 2009
Severe Disease Epidemic Narratives: Description of Clinical Management and Challenges Experienced in Winnipeg
ICUs. PHAC Conference: Severe H1N1 Disease: Preventing Cases, Reducing Mortality. (Winnipeg, MB) Sept 2,
2009
Adjunctive therapies –what do you have left when oseltamivir fail. PHAC Conference: Severe H1N1 Disease:
Preventing Cases, Reducing Mortality. (Winnipeg, MB) Sept 3, 2009

Severe H1N1 Infection in the ICU. H1N1 Mini-symposium. Weimar Sepsis Update: Sepsis Goes Public. 4 th
International Congress on Sepsis and Mult-iorgan Dysfunction. (Weimar, Germany) Sept 9, 2009
Strategies to prevent antibiotic delays. Rationale use of antibiotics in sepsis. Weimar Sepsis Update: Sepsis Goes
Public. 4 th International Congress on Sepsis and Multi-organ Dysfunction. (Weimar, Germany) Sept 10, 2009
H1N1: Description of Clinical Management and Challenges Experienced in Winnipeg ICUs. Primera Pandemia de
Gripe en UCIs, Sociedad Espanola de Medicina Intensiva, Critica y Unidades Coronarias (Madrid, Spain) Oct 5,
2009
Severe H1N1 Infection in Canada. Primera Pandemia de Gripe en UCIs, Sociedad Espanola de Medicina
Intensiva, Critica y Unidades Coronarias (Madrid, Spain) Oct 5, 2009
Speed is Life: Optimizing Antimicrobial Management of Septic Shock. Critical Care Grand Rounds, Servicio de
Medicina Intensiva y Crítica Hospital Universitari de Tarragona Joan XXIII (Tarragona, Spain) October 6, 2009
H1N1: Description of Clinical Management and Challenges Experienced in Winnipet ICUs, Servicio de Medicina
Intensiva y Crítica Hospital Universitari de Tarragona Joan XXIII (Tarragona, Spain) October 7, 2009
ICU Management of Severe H1N1 Infection. WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009
Influenza (Washington, DC) October 14, 2009
Epidemiology of Septic Shock in Canada. Critical Care Canada Forum (Toronto, ON) October 26, 2009
Fungal Septic Shock. Critical Care Canada Forum (Toronto, ON) October 26, 2009
Diagnosis and Management of Fungal Sepsis. Critical Care Canada Forum (Toronto, ON) October 26, 2009
Pathology of Severe H1N1 Infection. Critical Care Canada Forum (Toronto, ON) October 27, 2009
Fungal Sepsis and Septic Shock. Critical Care Canada Forum (Toronto, ON) October 27, 2009
The Right Antibiotic at the Right Time. Brazilian Congress of Critical Care Medicine (Sao Paulo, Brazil) Nov 11,
2009
Current Evidence: Monotherapy vs Combination Therapy in Septic Shock. Brazilian Congress of Critical Care
Medicine (Sao Paulo, Brazil) Nov 11, 2009
Myocardial Dysfunction in Sepsis and Septic Shock: Diagnosis and Treatment. Brazilian Congress of Critical Care
Medicine (Sao Paulo, Brazil) Nov 12, 2009
Speed is Life: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. St.
George’s Hospital (South London, England) Dec 14, 2009
Speed is Life: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. British
Intensive Care Society Annual Meeting (London, England) Dec 14, 2009
Optimizing Outcomes in Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock
(CATSS) Database. Sheffield Hallam Teaching Hospital (Sheffield, England) Dec 15, 2009
Speed is Life: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Aberdeen
Royal Infirmary (Aberdeen, Scotland) Dec 16, 2009
Optimizing Outcomes in Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock
(CATSS) Database. University of Glasgow Medical School (Glasgow, Scotland) Dec 16, 2009

Speed is Life: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. University
College (London) Hospital (London, England) Dec 17, 2009
Optimizing Outcomes in Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock
(CATSS) Database. King’s College Hospital (London, England) Dec 17, 2009
How research is driving clinical outcomes / tales from the front lines of the H1N1 epidemic. Manitoba Health
Research Council Presentation. Manitoba Legislature (Winnipeg, MB) Feb 16, 2010
Lessons from the frontlines of the H1N1 pandemic. American Thoracic Society State of the Art Review Course.
(Miami, FL) Feb 26, 2010
My experience with H1N1. 30 th International Symposium on Intensive Care and Emergency Medicine. (Brussels,
Belgium) March 9, 2010
ECMO in H1N1-associated respiratory failure. 30 th International Symposium on Intensive Care and Emergency
Medicine. (Brussels, Belgium) March 10, 2010
Antimicrobials in septic shock. 30 th International Symposium on Intensive Care and Emergency Medicine.
(Brussels, Belgium) March 10, 2010
Antibiotic therapy: Optimal timing. 30 th International Symposium on Intensive Care and Emergency Medicine.
(Brussels, Belgium) March 11, 2010
Improving sepsis management: Speed is life. 30
Medicine. (Brussels, Belgium) March 11, 2010 th International Symposium on Intensive Care and Emergency
Unilateral Withdrawal: An 11th Commandment? Canadian Critical Care Conference (Whistler, BC) March 18, 2010
Panelist. Lessons from the H1N1 Pandemic in Canada. Canadian College of Health Service Executives/Health
Professional’s Roundtable for Strategy Meeting. (New York, NY) April 15, 2010
Lessons from the Manitoba H1N1 Epidemic. The Critical Eye Nursing Conference. McPhillips Street Station.
(Winnipeg, MB) April 19, 2010
Lessons from the Manitoba H1N1 epidemic. Roche Medical Advisory Board Meeting (Toronto, ON) April 19, 2010
Pandemic H1N1: From the front lines of the Winnipeg ICUs. Pan-infORM Workshop: The First Influenza
Pandemic of the 21st Century: Canada's Response, Lessons Learned, and Challenges Ahead. National
Biodiagnostics Institute (Winnipeg, MB) April 19, 2010
Speed is life: The role of rapid, appropriate antimicrobial therapy in outcome of septic shock. XLV Congresio
Nationale de la SEMICYUC 2010. SEMICYUC:Spanish National Critical Care Society (Malaga, Spain) June 14,
2010.
Speed is life but a sledgehammer helps too: The importance of early pharmacokinetic/pharmacodynamic optimization in outcome of septic shock . XLV Congresio Nationale de la SEMICYUC 2010. SEMICYUC:Spanish
National Critical Care Society (Malaga, Spain) June 14, 2010.
Pandemic H1N1: Lessons learned in the ICU. XLV Congresio Nationale de la SEMICYUC 2010.
SEMICYUC:Spanish National Critical Care Society (Malaga, Spain) June 15, 2010.
Philippe Lagace-Wiens
Optimizing Blood Culture Collection: Given to Misericordia Urgent Care, Saint-Boniface Hospital Nursing Units.
February 2, 3, 10, 11, 17, 23 and 25, May 28 and June 1, 2010.

Optimizing Wound Swab Collection: Given to Misericordia Urgent Care, Saint-Boniface Hospital Nursing Units.
February 10 and 17, 2010.
Interpretation of Peritoneal Dialysis Cultures: Given to Peritoneal Dialysis Unit and Medicine wards. March 29,
2010.
Confessions of a Mosquito: Given to the Manitoba Travel Health Network Conference. April 22, 2010.
It’s Raining bats and Dogs: Given to the Manitoba Travel Health Network Conference. April 23, 2010.
Parasitology for technologists: Given to Red River College. June 4, 2010.
Linda Larcombe
Presentations on Housing and tuberculosis to:
1.
Northlands Denesuline First Nation and National Grand Chief Atleo,
2.
Assembly of Northern Manitoba Chiefs,
3.
Manitoba Chiefs Task Force on Health
4.
Southeast Tribal Council
5.
First Nation Inuit and Health Branch
Richard Lester
Canadian Pediatric Society: Vancouver, June 2010. “Congenital Syphilis: A Lingering Menace”
Yan Li
“Identification of novel swine H1N1 influenza virus”. Capital Institute of Pediatrics, Beijing, China (August 27,
2009).
“Detection of novel swine-origin H1N1 influenza virus from Mexican samples”. Beijing Centre for Disease
Prevention and Control (September 3, 2009).
“Monitoring the evolution of the 2009 pandemic H1N1” at the 8 th Beijing Forum on Public Health – 2009
Influenza A (H1N1) Prevention and Control Symposium, Beijing, China (January 25-27, 2010).
Stephen Moses
Invited speaker, South Asia Regional Knowledge Forum: Sharing Lessons Learned from Community Innovations
Reducing Stigma and Other Barriers to HIV Prevention, New Delhi, India, March 15-16, 2010. “Responding to violence in the context of HIV prevention programming in Karnataka”.
Invited speaker, Washington Global Health Alliance Discovery Series, Seattle, Washington, USA, May 29, 2010.
“Male circumcision for HIV prevention: science and policy”.
Invited lecturer, University of Washington Department of Global Health, Implementation Science in Health course
(GH 590B), Seattle, Washington, USA, May 20, 2010. “Male circumcision”.
Invited lecturer, University of Washington, HIV/STI Prevention Research Methods course (GH 563/EPI 549),
Seattle, Washington, USA, May 17, 2010. “Scaling up a focused HIV prevention program for high risk groups in
India: assessing impact in the absence of a randomized trial design”.
Invited Lecturer, University of Toronto, Academic Research day, Department of Microbiology and Infectious
Disease, Toronto, Ontario, Canada, June 15, 2010. “Male circumcision for HIV prevention: the science and scaleup in Africa.

Michael Mulvey
Invited Speaker. Medical Rounds. Emerging Antimicrobial Resistance in Canada. August 6, 2009, University of
Calgary.
. Symposium on Infectious Diseases, the Invited Speaker. Epidemiological Surveillance on
Research Center in Tropical Diseases of the University of Costa Rica. March 1-4, 2010, Costa Rica.
Lindsay Nicolle
Invited speaker/panelist. “Asymptomatic vs symptomatic UTI’s. Evidence based definitions, diagnosis, clinical course, management, implications”. Mini-conference on genitourinary infections. Groton, CT. June 29, 2009.
Invited speaker: “When is a UTI a UTI? Interpreting the Quantitative Urine Culture”, Sept 13, 2009.
Co-moderator Symposia:
“Emerging Clinical Issues in the Management of UTI’s” 13 Sept.
“New Issues in Managing STI’s that Every Clinician Should Consider” 14 Sept.
49 th ICAAC San Francisco September 12-15, 2009
Invited speaker:
Forum: Infection Control in Long Term Care “What are the Main Challenges for Infection Control in Long Term
Care Facilities. Princess Margaret Hospital, Hong Kong, October 15, 2009.
Workshop: Infection Control in Long Term Care Facilities, Hong Kong, October 16, 17, 2009. “Prevention of
Catheter-Associated Urinary Tract Infection: Key Issues in New HICPAC Guidelines”.
“Common Infections and Diagnostic Issues in LTCF’s”.
Invited Speaker: “Healthy Aging: Preventing infections in the elderly.” Bug Day, Winnipeg October 20, 2009.
Invited Speaker: “Research priorities in non-acute care settings” in Symposium “Infection Prevention and Control
Challenges in Non-Acute Care Settings” at Fifth Decennial International Conference on Healthcare-Associated
Infections, Atlanta, Georgia March 19, 2010.
Invited Speaker: “New developments and changing concepts for urinary tract infections” at 32
Infectious Diseases Symposium, Swiss Society for Infectious Diseases, Lucerne April 22, 2010. nd Annual
Rosanna Peeling
Jul 2009 “Malaria Diagnostics”. Global Fund Consultation on Quality Assurance, Geneva,
Switzerland.
Aug 2009 “Keynote address - challenges of promoting global health and need for POC tests” (San
Ping Wang Memorial Lecture).
“Diagnostics to Improve Global Health: Promises and Challenges” presented at the First
Annual Global Health Diagnostics Course: Advanced Didactic and Laboratory Training for
Global Health, University of Washington, USA.
Nov 2009 “Results and progress of evaluation studies on commercially available dengue diagnostic tests: Implications on WHO recommendations and quality assurance of dengue diagnostic tests”. Second WHO WPRO Regional Dengue Programme Manager Meeting,
Hanoi, Vietnam.
Nov 2009 “Overview: current status of CD4 technologies” Meeting on Laboratory-Based Treatment
Monitoring: Current Status of Technology, Research and Application/Best Uses, Office of the Global AIDS Coordinator, Washington, USA.

Nov 2009
Feb 2010
“STD Update: Can we move beyond Syndromic Treatment?” and “Rapid diagnostic tools in theory and practice” (co-chair)
American Society for Tropical Medicine and Hygiene, Washington, USA
“How do we measure the impact of diagnostics?” WHO TDR Diagnostics Evaluation
Expert Panel Meeting, Geneva, Switzerland
Mar 2010 “Challenges and Opportunities for Diagnostics and Assays” (moderator). Symposium on development, evaluation and regulatory issues of dengue vaccines in Brazil, PDVI,
Salvador, Brazil.
Mar 2010 “Diagnostics to Improve Global Health: Promises and Challenges” Chair, Plenary Lecture
– 11 th Sir Dorabji Tata Symposium, Bangalore, India
Apr 2010 “Regional Innovation Networks for Research and Development on drugs and diagnostics for Infectious Diseases that Disproportionately Affect Developing Countries”. China
Pharmaceutical R&D Summit 2010, Shanghai, China
May 2010 “Role of molecular diagnostics on STI”. International Union against Sexually Transmitted
Infections, Bali, Indonesia.
May 2010 “Accessible Quality-Assured Diagnostic Tests for Sexually Transmitted Diseases” National
STI conference, Hainan China
May 2010 “Point of care testing”. Clinical Update: Chlamydia. Royal Society of Medicine, London,
UK.
Jun 2010 “Drugs and Diagnostics Innovation in the Combat against Infectious
Diseases of Poverty” The WHO TDR Joint Coordinating Board meeting, Shanghai, China
“Point of care diagnostics”. Second Annual Global Health Diagnostics Course, University of Washington, USA.
Pierre Plourde
Preparing Healthcare Workers for International Travel (CME presented to family physicians in Steinbach, Manitoba
– South Eastman RHA) – September 30, 2009
HIV Nondisclosure – Human Nature or Criminal Behaviour? (presentation to Sexually Transmitted and Blood
Borne Infections interest group, Mount Carmel Clinic, Winnipeg) – October 13, 2009
Pre-Travel Risk Assessment (GSK-sponsored CME presented to family physicians in Winnipeg) – October 17, 2009
Intoxications and Envenomations: The Kiss of Death! (presentation at Bug Day, Health Sciences Centre,
Winnipeg) – October 20, 2009
Disclosing HIV Status – Revisiting the Issues of Legality and Ethics (presentation at HIV Conference for Prairie
Clinical and Non-Clinical Service Providers and PHA’s, Winnipeg) – October 27, 2009
Pragmatic Solidarity – A Preferential Option for the Poor (presentation for Creative Retirement's Current World
Issues Lecture Series, Globe Theatre, Winnipeg) – March 25, 2010
CATMAT Update (Manitoba 8 th Annual Travel Health Conference, Winnipeg) – April 22, 2010
Reaching VFR [Visiting Friends and Relatives] Travellers (Manitoba 8
Winnipeg) – April 23, 2010 th Annual Travel Health Conference,

Envenomation (Manitoba 8 th Annual Travel Health Conference, Winnipeg) – April 23, 2010
Pragmatic Solidarity – A Preferential Option for the Poor (Manitoba 8
Winnipeg) – April 23, 2010 th Annual Travel Health Conference,
Working in “Difficult Partnership” Countries (CHICA Manitoba Annual Education Conference, Winnipeg) – June 18,
2010
WRHA pH1N1 Response (CHICA Manitoba Annual Education Conference, Winnipeg) – June 18, 2010
Frank Plummer
September 2009. Anticipating where the puck is going to be: using advanced technologies to keep ahead in the evolutionary struggle with the microbial world, Bacon and Eggheads Lecture, Parliament of Canada.
Allan Ronald
April 2010 – Makerere University – “Making Pathogens Extinct”.
Ethan Rubinstein
UK, Royal Society of Medicine- Stpahylococcal pneumonia
Meenu Sharma
Evaluation of a real-time in-house methodology for Mycobacterium tuberculosis detection assay from patient samples, 2010. University of Nairobi and university of Manitoba collaborative meeting.
Mycobacteriology Services and Polices: National Laboratory Perspective, 2010. Winnipeg Regional Health
Authorties, Manitoba.
Stuart Skinner
May 13, 2010. “Late Evidence, Delayed Action: Late Presentation to Care and its Implications in the Continuing of Care in the Prairies”. CAHR (Canadian Association of HIV Research), Saskatoon, Sask.
Jim Strong
Outbreak Management in the Field. Presented to East-West Alliance Conference 2010. Brody Centre, Winnipeg,
Manitoba, June 3-4, 2010
Paul Van Caeseele
Diagnosis: Lessons learned – current recommendations vs. clinical reality. Severe H1N1 Disease: Preventing cases, Reducing Mortality Conference, Winnipeg, Manitoba, September 2 & 3, 2009.
Role of a Public Health Laboratory during Pandemic. CHICA Manitoba Infection Prevention and Control
Conference, Winnipeg, MB. June 18, 2010.
Andrew Walkty
Infectious Diseases Half-day (local) - Pneumonia

Hana Weingartl
Susceptibility of pigs to
and their potential as an intermediate host species.
Hana M. Weingartl, James Neufeld and Gary Kobinger, Epizone meeting, St. Malo, France, June 7-10; 2010
Establishing diagnostic capability for Rift Valley fever virus in livestock.
NATO workshop: Managing global environmental threats to air, water and soil, Ljubljana, June 28-30, 2010
John Wylie
The social epidemiolopy of STBBI in Manitoba. Invited to present at the “Real issues regarding newcomers and
HIV: social, medical, and other aspects of the social determinants of health” conference held in Winnipeg, MB,
March 11-12, 2010.
The social epidemiology of bloodborne pathogens in Manitoba. Invited to give a CME presentation to HIV clinicians in Manitoba. January 4 th , 2010.
Social network analysis – theory and practical perspective. Invited to give a two day workshop at Sichuan
University, Chengdu, China. Jan. 21-22, 2010.
Street-involved youth in Canada. Invited to give a seminar to Faculty of the University of Antioquia and Municipal
Government representatives in Medellin, Colombia. November 25, 2009.
PFGE, Pulsenet and Enteric Surveillance in Manitoba. Requested to present to the Communicable Disease Control
Branch of Manitoba Health. October 30, 2009.
Xi Yang
Keynote Speaker: China-Canada Collaborative Research. Second International Symposium on Recent Advances in
Basic, Clinical and Social Medicine. Shantou, Nov 2009
Invited Talk: NKT/DC interaction in chlamdyial infection. Guangzhou, Nov 2009
Invited Talk: SCI Paper writing and review, Tianjin, Nov 2009
Invited Talk: Give more get more? The NKT/DC story. International symposium on frontiers of immunology,
Winnipeg, September 2009.
Xiao-Jian Yao
Efficient inhibition of HIV-1 replication mediated by modified APOBEC3G fusion proteins: A Novel anti-HIV gene therapy strategy. World Congress of Genes, Fushan, China, Dec 04, 2009.
George Zhanel
“Treatment of multi-drug resistant
and
spp.: Optimizing antimicrobial use and focusing on new antimicrobials”. Presented at a specialist update, Phoenix, Arizona, July 9, 2009.
“Comparison of the new carbapenems: Which to put on the formulary”. Presented at a specialist update, Las
Vegas, Nevada, July 10, 2009.
“Antimicrobial resistant infections on the islands compared to the mainland: What to do”. Presented at a specialist update, Honolulu, Hawaii, July 29, 2009.
“Treatment of infectious diseases in the days of multi-drug resistant pathogens”. Presented at a specialist update, Honolulu, Hawaii, July 29, 2009.

“Update on the status of antimicrobial resistant pathogens in North America: Pathogens and solutions”.
Presented at the Canadian Society of Hospital Pharmacy (CSHP) annual meeting, Winnipeg, Manitoba, August
11, 2009.
“Washing your hands and using antimicrobials wisely, the key aspects to reduce the spread of resistant infections”. Presented at a specialist update, Samaritan Hospital, Peoria, Illinois, August 25, 2009.
“The importance of antimicrobial pharmacodynamics in optimizing infectious diseases treatment”. Presented at a specialist update, Peoria, Illinois, August 25, 2009.
“How to use B-lactams in the treatment of infectious diseases”. Presented at a specialist update, Indianapolis,
Illinois, August 26, 2009.
“Describing the spread of resistant pathogens in North America”. Presented at a specialist update, Indianapolis,
Illinois, August 26, 2009.
“The rapid evolution of multi-drug resistant (MDR) ESBL and KPC Enterobacteriaceae in North America”.
Presented at a specialist update, New York City, New York, September 30, 2009.
“Reducing the spread of resistant superbugs: Bacteria and Viruses”. Presented at a specialist update, Houston
Infectious Diseases Society, Houston, Texas, October 7, 2009.
“Making formulary decisions for antimicrobials: What all should be considered”. Presented at a clinical pharmacists update, Houston Texas, October 8, 2009.
“An overview of the CAN-R website: Canada’s premiere website for antimicrobial resistance”. Presented at a CIHR antimicrobial resistance database planning session, McMaster University, Hamilton, Ontario, October 15, 2009.
“Review of macrolide usage and macrolide resistance in Canada: 1998-2008”. Presented at a specialist update,
Toronto, Ontario, November 27, 2009.
“The Baddest bug: Comparison of MRSA, ESBL/KPC producers and
spp/
”.
Presented at the 44 th American Society of Hospital Pharmacy (ASHP) Midyear Clinical Meeting, Las Vegas,
Nevada, December 8, 2009.
“Review of the mechanisms of action and resistance, microbiology, pharmacokinetics and pharmacodynamics of doripenem: Comparison to other carbapenems”. Presented at the Society of Critical Care Medicine (SCCM)
Symposium, Miami, Florida, January 8, 2010.
“Treating infectious diseases in 2010: How to proceed ? ”. Presented at a specialist update, Indianapolis, Indiana,
January 27, 2010.
“New antimicrobials to combat resistant infections: What should we do with them ? ”. Presented at internal medicine rounds, Hendricks Regional Hospital, Indianapolis, Indiana, January 28, 2010.
“Review of probiotics and other prevention strategies to minimize antimicrobial resistant infections ” Presented to the Internal Medicine Residents, Winnipeg, Manitoba, February 23, 2010.
“Comparison of ertapenem, imipenem, meropenem and doripenem ” Presented at a Clinical Pharmacists Update,
Montreal, Quebec, March 20, 2010.
“Pharmacokinetics and pharmacodynamics of aminoglycosides, fluoroquinolones and  -lactams: What is the state of the art ? ” Presented at a Clinical Pharmacists Update, Montreal, Quebec, March 20, 2010.
“Germs: You cant live with them and you cant live without them. Presently at the Reh-Fit foundation annual healthy living awards. Winnipeg, Manitoba, April 15, 2010.

“All the facts about carbapenems” Presented at a Clinical Pharmacists Update, Toronto, Ontario, April 16, 2010.
“Pharmacokinetics and pharmacodynamics of penicillins, cephalosporins and carbapenems” Presented at a Critical care Specialists Update, Toronto, Ontario, April 17, 2010.
“The evolution of
serotypes in Canada: Implications for vaccination. ” Presented at a medical/economic update meeting, Toronto, Ontario, April 20, 2010.
“Treating infectious diseases in rural/northern medical units.” Presented at a northern medical edicine/pharmacy update meeting, Winnipeg, Manitoba, May 28, 2010.
“Review of the Crystal session: Methods and results.” Presented at the national champions meeting of managing surgical intra-abdominal infections (SIAI), Toronto, Ontario, June 18, 2010.
“Role of carbapenems in the treatment of surgical intra-abdominal infections (SIAI).” Presented at the national champions meeting of managing surgical intra-abdominal infections (SIAI), Toronto, Ontario, June 18, 2010.
“Vaccination, probiotics, infection control and prudent antibiotic: Keys to managing infectious diseases.”
Presented at a family physician update, Winnipeg, Manitoba, June 19, 2010.
“New aminoglycosides: Needed to treat multi-drug resistant organisms.” Presented at Ribs on the Red, meeting with Intellectual Ventures”, Winnipeg, Manitoba, June 23, 2010.
Wen Zhong
Zhong, W. (2009). Development of Bio-medicated Nanofibers for Wound Care. HighTex, Montreal, November
2009.
Alcock, M. & Zhong, W. (2009). Development of Standards of Measuring Properties of Hemp. The 106th Scientific
Session of the Institute of Textile Science, Winnipeg, September, 2009.